title: [Features of correction of phosphate-calcium metabolism disorders in terminal renal failure].
abstract: Mineral metabolism was studied in 27 hemodialyzed patients with terminal chronic renal failure (CRF). Because of progressing hyperparathyroidism the initial treatment included calcium drugs, active forms of vitamin D (videchol, oxidevit), almagel, bicarbonate hemodialysis and hemosorption. The condition improved in 8 and stabilized in 12 patients. Conservative treatment was ineffective in 7 patients who consequently underwent total (4 cases) or subtotal (3 cases), parathyroidectomy. The response was achieved in 3, stabilization in 3, the disease advanced in 1 patients.
authors.forename: V S
authors.initials: VS
authors.lastname: Pilotovich
authors.forename: V P
authors.initials: VP
authors.lastname: Romanovich
authors.forename: L M
authors.initials: LM
authors.lastname: Shilaĭ
authors.forename: N N
authors.initials: NN
authors.lastname: Tukaĭ
mesh_terms: D000328:Adult; D000536:Aluminum Hydroxide / Q000627:therapeutic use; D000863:Antacids / Q000627:therapeutic use; D001566:Benzocaine / Q000627:therapeutic use; D002118:Calcium / Q000378:metabolism* / Q000627:therapeutic use; D004338:Drug Combinations; D005260:Female; D006464:Hemoperfusion; D006801:Humans; D007676:Kidney Failure, Chronic / Q000378:metabolism / Q000628:therapy*; D008276:Magnesium Hydroxide / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010710:Phosphates / Q000378:metabolism*; D006435:Renal Dialysis; D014807:Vitamin D / Q000627:therapeutic use
chemical_list: D000863:Antacids; D004338:Drug Combinations; D010710:Phosphates; C010016:aluminum hydroxide, benzocaine, magnesium hydroxide drug combination; D014807:Vitamin D; D000536:Aluminum Hydroxide; D008276:Magnesium Hydroxide; D002118:Calcium; D001566:Benzocaine
vernacular_title: Osobennosti korrektsii narusheniĭ fosfatno-kal'tsievogo obmena pri terminal'noĭ pochechnoĭ nedostatochnosti.